NCLH vs SILO · P/E 16, rev $4.97B vs rev $18.0K
Norwegian Cruise Line Holdings Ltd (NCLH) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. SILO currently screens at market cap $4.4M.
Not investment advice. Open the NCLH and SILO stock pages for the full models.
Not investment advice.